SCHEMBL20867139

SCHEMBL20867139

N=C(CC(F)(F)F)OC(=N)NC1N=C(c2ccccc2)c2ccccc2NC1=O

nearest known ligand 0.59

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ CCKBR P32239 13/20 0.59
▸ CCKAR P32238 9/20 0.59
▸ NOTCH1 P46531 2/20 0.54
▸ RBPJ Q06330 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20866641 0.90 CCKBR (0.57) CCKBRCCKARNOTCH1RBPJ
SCHEMBL20866650 0.86 CCKBR (0.58) CCKBRCCKAR
SCHEMBL20866659 0.85 CCKBR (0.62) CCKBRCCKAR
SCHEMBL24612080 0.85 CCKBR (0.58) CCKBRCCKAR
SCHEMBL20867167 0.84 CCKBR (0.57) CCKBRCCKAR
SCHEMBL20866819 0.83 CCKBR (0.63) CCKBRCCKAR
SCHEMBL20867057 0.83 CCKBR (0.55) CCKBRCCKAR
SCHEMBL20866718 0.83 CCKBR (0.60) CCKBRCCKARNOTCH1RBPJ
SCHEMBL24612045 0.83 CCKBR (0.74) CCKBRCCKAR
SCHEMBL20866648 0.82 CCKBR (0.59) CCKBRCCKAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3324977-B1 BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS ENANTA PHARM INC (US) 2022-07-13 — — EP disclosed
WO-2019067864-A1 COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2019-04-04 — — WO disclosed
Send feedback